These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial disease--against]. Terrioux P Rev Mal Respir; 1999 Jan; 16 Suppl 3():S76-7. PubMed ID: 10088258 [No Abstract] [Full Text] [Related]
11. Acute exacerbations of obstructive lung disease. What to do when immediate care is crucial. Fromm RE; Varon J Postgrad Med; 1994 Jun; 95(8):101-6. PubMed ID: 7911236 [TBL] [Abstract][Full Text] [Related]
12. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive pulmonary disease]. Bootsma GP; Van Weel C; Van Herwaarden CL Ned Tijdschr Geneeskd; 1999 Apr; 143(14):764. PubMed ID: 10347634 [No Abstract] [Full Text] [Related]
18. [Beta 3-receptors: incidence and properties, possible clinical significance]. Gullestad L; Osnes JB Tidsskr Nor Laegeforen; 1995 Jan; 115(1):45-9. PubMed ID: 7846660 [TBL] [Abstract][Full Text] [Related]
19. Beta-blockers are safe in patients with chronic obstructive pulmonary disease, but only with caution. Cazzola M; Matera MG Am J Respir Crit Care Med; 2008 Oct; 178(7):661-2. PubMed ID: 18796649 [No Abstract] [Full Text] [Related]
20. [Methodological aspects of the testing of beta-blockers in patients with obstructive lung disease]. Albrektsen T; Legemidler H Tidsskr Nor Laegeforen; 1979 Mar; 99(8):416-9. PubMed ID: 34900 [No Abstract] [Full Text] [Related] [Next] [New Search]